At PRA Health Sciences, we have contributed to the development of numerous drugs and supported thousands of clinical studies in over 80 countries covering nearly every major therapeutic area and disease indication. Our experience is broad, but several areas of exceptional strength and expertise align with your clinical development pipeline.

CNS Expertise:
PRA is an industry leader providing innovative solutions for CNS, having contributed to the successful market approvals of 16 CNS drugs in a number of indications including ADHD, Parkinson’s, cervical dystonia, epilepsy, migraine, pain, arthritis and MS. We provide a broad variety of experimental pain models available to study the pharmacodynamics of pain compounds in healthy volunteers as well as industry-leading expertise in human abuse liability (HAL). HAL data is now considered a critical piece of information during the NDA review process for most treatments involving CNS indications and those with abuse-deterrent or tamper-resistant properties.

Oncology & Hematology Expertise:
As a recognized leader in conducting complex, global oncology and hematology trials, PRA has contributed to the approval of 12 important oncology/hematology drugs. During the last five years, PRA has participated in 400+ oncology and hematology projects globally in every phase and virtually every indication, including supportive care.

Contact us to learn how our expertise can help you meet your needs.

To save lives, or enable people to live better lives, is no small thing. That’s why we have invested heavily in hiring world-class therapeutic experts to support our clients, project teams and investigators throughout the drug development process.